Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Learn More About Zacharon Pharmaceuticals
Zacharon Pharmaceuticals
Reports Graph
New class of small molecule glycan-targeted drugs to address substantial unmet needs, including: lysosomal storage, oncology, inflammation, and other diseases
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next